Compare CRBP & CD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBP | CD |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 227.2M |
| IPO Year | 2014 | 2014 |
| Metric | CRBP | CD |
|---|---|---|
| Price | $11.31 | $3.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $45.50 | N/A |
| AVG Volume (30 Days) | ★ 516.3K | 248.2K |
| Earning Date | 05-08-2026 | 08-31-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,822,272.00 | $1,867,068.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $116.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 97.62 | ★ 277.93 |
| 52 Week Low | $7.12 | $2.10 |
| 52 Week High | $20.56 | $14.10 |
| Indicator | CRBP | CD |
|---|---|---|
| Relative Strength Index (RSI) | 66.21 | 44.16 |
| Support Level | $7.62 | $2.96 |
| Resistance Level | $11.64 | $3.22 |
| Average True Range (ATR) | 0.60 | 0.46 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 83.08 | 8.06 |
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Chaince Digital Holdings Inc is digital fintech company providing access to the growing AI-powered infrastructure, blockchain, and digital assets. Its three core business lines include: blockchain and digital asset solutions, AI and HPC infrastructure, developing liquid cooling solutions for AI data centers and comprehensive financial services through Chaince Securities,LLC a FINRA-registered broker-dealer, and RIA.